Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery

Ratziu, 2010, A position statement on NAFLD/NASH based on the EASL 2009 special conference, J Hepatol, 53, 372, 10.1016/j.jhep.2010.04.008 Fracanzani, 2010, Risk of non alcoholic steatohepatitis and fibrosis in patients with non alcoholic fatty liver disease and low visceral adiposity, J Hepatol, 54, 1244, 10.1016/j.jhep.2010.09.037 Zimmermann, 2011, C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients, J Hepatol, 55, 660, 10.1016/j.jhep.2010.12.017 Masterton, 2010, Coffee and the liver: a potential treatment for liver disease?, Eur J Gastroenterol Hepatol., 22, 1277, 10.1097/MEG.0b013e32833cca96 Cadden, 2007, Review article: possible beneficial effects of coffee on liver disease and function, Aliment Pharmacol Ther., 26, 1, 10.1111/j.1365-2036.2007.03319.x Gelatti, 2005, Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study, J Hepatol, 42, 528, 10.1016/j.jhep.2004.11.039 Birerdinc, 2012, Caffeine is protective in patients with non-alcoholic fatty liver disease, Aliment Pharmacol Ther, 35, 76, 10.1111/j.1365-2036.2011.04916.x Molloy, 2011, Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis, Hepatology, 10, 24731 1991, Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel, Ann Intern Med, 115, 956, 10.7326/0003-4819-115-12-956 Wallace, 2002, The assessment of insulin resistance in man, Diabet Med, 19, 527, 10.1046/j.1464-5491.2002.00745.x Alberti, 2006, Metabolic syndrome – a new world-wide definition. A Consensus Statement from the International Diabetes Federation, Diabet Med, 23, 469, 10.1111/j.1464-5491.2006.01858.x Brunt, 1999, Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions, Am J Gastroenterol, 94, 2467, 10.1111/j.1572-0241.1999.01377.x Kleiner, 2005, Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, 41, 1313, 10.1002/hep.20701 Higdon, 2006, Coffee and health: a review of recent human research, Crit Rev Food Sci Nutr, 46, 101, 10.1080/10408390500400009 Modi, 2010, Increased caffeine consumption is associated with reduced hepatic fibrosis, Hepatology, 51, 201, 10.1002/hep.23279 Costentin, 2011, Association of caffeine intake and histological features of chronic hepatitis C, J Hepatol, 54, 1123, 10.1016/j.jhep.2010.08.027 Tanaka, 2007, Inverse association between coffee drinking and the risk of hepatocellular carcinoma: a case-control study in Japan, Cancer Sci, 98, 214, 10.1111/j.1349-7006.2006.00368.x Montella, 2007, Coffee and tea consumption and risk of hepatocellular carcinoma in Italy, Int J Cancer, 120, 1555, 10.1002/ijc.22509 Freedman, 2011, Coffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C, Gastroenterology, 140, 1961, 10.1053/j.gastro.2011.02.061 Gressner, 2009, Less Smad2 is good for you! A scientific update on coffee’s liver benefits, Hepatology, 50, 970, 10.1002/hep.23097 Crozier, 2012, Espresso coffees, caffeine and chlorogenic acid intake: potential health implications, Food Funct, 3, 30, 10.1039/C1FO10240K Kalthoff, 2010, Coffee induces expression of glucuronosyltransferases by the aryl hydrocarbon receptor and Nrf2 in liver and stomach, Gastroenterology, 139, 1699, 10.1053/j.gastro.2010.06.048 Ouyang, 2008, Fructose consumption as a risk factor for non-alcoholic fatty liver disease, J Hepatol, 48, 993, 10.1016/j.jhep.2008.02.011 Abdelmalek, 2010, Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease, Hepatology, 51, 1961, 10.1002/hep.23535 Lim, 2010, The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome, Nat Rev Gastroenterol Hepatol, 7, 251, 10.1038/nrgastro.2010.41 Tetri, 2008, Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent, Am J Physiol Gastrointest Liver Physiol, 295, G987, 10.1152/ajpgi.90272.2008 Ma, 2011, Sucrose counteracts the anti-inflammatory effect of fish oil in adipose tissue and increases obesity development in mice, PLoS One, 6, e21647, 10.1371/journal.pone.0021647 Roncal-Jimenez, 2011, Sucrose induces fatty liver and pancreatic inflammation in male breeder rats independent of excess energy intake, Metabolism, 60, 1259, 10.1016/j.metabol.2011.01.008 Dekker, 2010, Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome, Am J Physiol Endocrinol Metab, 299, E685, 10.1152/ajpendo.00283.2010